$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK'd & More
02:10pm, Friday, 24'th Jan 2020
Company news slowed somewhat this week, perhaps as some took the federal Martin Luther King Jr. Day holiday away from the office and others recovered from
Krystal Biotech Breaks Ground On Second Commercial Gene Therapy Manufacturing Facility
01:00pm, Friday, 24'th Jan 2020
Krystal Biotech, Inc. (KRYS), a gene therapy company developing medicines to treat rare diseases, announced today the ground breaking of the second commercial gene therapy facility in Findlay Township
Krystal Biotech Appoints Jennifer Chien as Chief Commercial Officer
01:00pm, Tuesday, 21'st Jan 2020
Krystal Biotech, Inc. (KRYS), a gene therapy company developing medicines to treat rare diseases, today announced the appointment of Jennifer Chien to the newly created position of chief commercial
Companies Like Krystal Biotech (NASDAQ:KRYS) Are In A Position To Invest In Growth
05:28pm, Thursday, 02'nd Jan 2020
We can readily understand why investors are attracted to unprofitable companies. Indeed, Krystal Biotech (NASDAQ:KRYS...
Krystal Biotech, Inc. (KRYS) is a Great Momentum Stock: Should You Buy?
05:00pm, Monday, 23'rd Dec 2019
Does Krystal Biotech, Inc. (KRYS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Hedge Funds Dropped The Ball On Krystal Biotech, Inc. (KRYS)
02:42am, Sunday, 15'th Dec 2019
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
The Zacks Analyst Blog Highlights: ACADIA, Compugen, Cue Biopharma, Epizyme and Krystal Biotech
04:56pm, Thursday, 12'th Dec 2019
The Zacks Analyst Blog Highlights: ACADIA, Compugen, Cue Biopharma, Epizyme and Krystal Biotech
5 Biotech Stocks Up More Than 100% This Year So Far
02:04pm, Wednesday, 11'th Dec 2019
The biotech sector recovers on the back of rising M&A; activities and pipeline successes in 2019 after a dismal 2018. Here we discuss five biotech companies recording impressive growth.
Krystal Biotech, Inc. (KRYS) Shares March Higher, Can It Continue?
01:50pm, Tuesday, 03'rd Dec 2019
As of late, it has definitely been a great time to be an investor in Krystal Biotech, Inc. (KRYS).
Cold sore sufferers like me are supposed to keep a stiff upper lip
11:53am, Tuesday, 16'th Jul 2019
It was on a Dalston dancefloor that I contracted herpes. Not — gasp — the genital kind, that would be a feat, but the cold-sore virus Herpes Simplex 1. He was a new boyfriend and through an innoce
Biotech Outlook 2019: Will the Pressure Continue? | INN
07:30am, Thursday, 20'th Dec 2018
With 2018 coming to an end, what's the biotech outlook? Next year will bring new investing opportunities for those in the space.
Sign In
Buy KRYS